25th May 2018 12:28
LONDON (Alliance News) - Bioquell PLC on Friday said it sold its MDH Defence business for an initial consideration of GBP400,000.
The pharmaceutical company said it can get a further contingent payment of up to GBP600,000 if MDH Defence wins a specific contract for which it is presently bidding within the next 12 months.
If successful, the deal promises to bring MDH Defence a revenue of GBP700,000 and margin of GBP200,000 during the second half of 2018.
For 2017, MDH Defence reported a revenue of GBP700,000 and operating loss of GBP35,000.
"I am pleased to have been able to reach agreement to exit this non-core business," said Executive Chairman Ian Johnson. "The disposal represents a further step in simplifying and reducing the complexity of the business and transitioning Bioquell's focus to its core products and services."
The stock was untraded at 314.90 pence on Friday.
Related Shares:
Bioquell